Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 12:12:1515724.
doi: 10.3389/fsurg.2025.1515724. eCollection 2025.

Analyzing the characteristics of Otitis media with effusion following SARS-CoV-2 infection in China

Affiliations

Analyzing the characteristics of Otitis media with effusion following SARS-CoV-2 infection in China

Xinxin Li et al. Front Surg. .

Abstract

Objective: This study investigates the characteristics of Otitis Media with Effusion (OME) secondary to the SARS-CoV-2 pandemic, and examines whether SARS-CoV-2 is present in middle ear effusions (MEE).

Methods: We analyzed patients diagnosed with SARS-CoV-2 who presented with ear fullness between December 15, 2022, and January 20, 2023. After obtaining a detailed medical history and conducting audiometric assessments, we confirmed OME and performed tympanocentesis to test for SARS-CoV-2 in the MEE following informed consent. Post-procedure, patients received nasal decongestants and oral/nasal corticosteroids. Follow-up consultations, tympanic membrane examinations, and audiometric evaluations were conducted 2-4 weeks later, with a final assessment at three months.

Results: Our clinic recorded 311 OME cases during the study period, accounting for 9.5% of all patients-a significant increase from 2.2% the previous year and 2.5% the following year. The peak incidence occurred one week post-infection. Among the 311 patients, 52 underwent tympanocentesis (33 males, 19 females). 20 patients had bilateral onset, while 32 had unilateral onset. 31 patients were cured after a single tympanocentesis, whereas 21 required two or more procedures. 17 patients tested positive for SARS-CoV-2 in the MEE, but only one simultaneously tested positive in nasal secretions. At the three-month follow-up, 59.6% of patients were cured, 30.8% showed improvement without full recovery, and 9.6% had no improvement. Factors such as poor mastoid pneumatization, nasopharyngeal obstruction, and comorbidities (hypertension, diabetes) affected treatment efficacy. Among the 52 patients, 37 had conductive hearing loss (CHL), and 15 had mixed hearing loss (MHL).

Conclusions: SARS-CoV-2 contributes to OME, primarily affecting one ear. The virus persists longer in MEE than in the upper respiratory tract, suggesting slower viral clearance in the middle ear compared to the nasopharynx. Conductive hearing loss (CHL) is the most common type post-infection, but mixed hearing loss (MHL) can also occur, particularly in older patients, with less favorable outcomes compared to CHL.

Keywords: COVID-19; SARS-CoV-2; conductive hearing loss; middle ear effusion (MEE); mixed hearing loss; otitis media with effusion (OME).

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
(A) Endoscopic image of typical OME, showing yellowish fluid in the tympanic chamber. (B) Pure tone audiometry and tympanometry in typical OME. There is a gap between air conduction and bone conduction curve in the right ear, tympanometry shows type B curve in the right ear.
Figure 2
Figure 2
Flow chart with patients in this study.
Figure 3
Figure 3
(A) The onset of ear fullness post-infection. (B) Time for medical visits post-infection.
Figure 4
Figure 4
(A) Duration of ear fullness in patients with COVID-19 positive in MEE, the longest time last 40 days. (B) Positive for SARS-CoV-2 nucleic acid in MEE by polymerase chain reaction (PCR) testing.

Similar articles

References

    1. Buzatto G, Tamashiro E, Proenca-Modena JL, Saturno TH, Prates M, Gagliardi TB, et al. The pathogens profile in children with otitis media with effusion and adenoid hypertrophy. PLoS One. (2017) 12(2):e0171049. 10.1371/journal.pone.0171049 - DOI - PMC - PubMed
    1. Al-Salim S, Tempero RM, Johnson H, Merchant GR. Audiologic profiles of children with otitis media with effusion. Ear Hear. (2021) 42(5):1195–207. 10.1097/AUD.0000000000001038 - DOI - PMC - PubMed
    1. Paing A, Elliff-O’Shea L, Day J, Joshi D, Arnold S, Brown TH, et al. Modifiable risk factors for developing otitis media with effusion in children under 12 years in high-income countries: a systematic review. Arch Dis Child. (2025) 110(1):45–51. 10.1136/archdischild-2024-327454 - DOI - PubMed
    1. Wu F, Zhao S, Yu B, Chen Y-M, Wang W, Song Z-G, et al. A new coronavirus associated with human respiratory disease in China. Nature. (2020) 579(7798):265–9. 10.1038/s41586-020-2008-3 - DOI - PMC - PubMed
    1. Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol. (2020) 92(4):401. 10.1002/jmv.25678 - DOI - PMC - PubMed

LinkOut - more resources